Preoperative antithrombin III activity predicts outcome after surgical repair of acute type A aortic dissection

Atherosclerosis

Volumn 186, Issue 1, 2006, Pages 107-112

  Sodeck, Gottfried H ^a   Schillinger, Martin ^a   Ehrlich, Marek P ^a   Grabenwoeger, Martin ^a   Exner, Markus ^a   Laggner, Anton N ^a   Domanovits, Hans ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aorta; Aortic dissection; Coagulation; Outcome; Prognosis

Indexed keywords

ANTITHROMBIN III;

ADULT; AGED; AORTA DISSECTION; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; EMERGENCY SURGERY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE;

ADULT; AGED; ANEURYSM, DISSECTING; ANTITHROMBIN III; AORTIC ANEURYSM; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VASCULAR SURGICAL PROCEDURES;

EID: 33645878927     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.06.031     Document Type: Article

References (21)

1. Ehrlich M.P., Ergin M.A., McCullough J.N., et al. Results of immediate surgical treatment of all acute type A dissections. Circulation 102 III (2000) 248-252
2. Hagan P.G., Nienaber C.A., Isselbacher E.M., et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283 (2000) 897-903
3. Mehta R.H., Suzuki T., Hagan P.G., et al., International Registry of Acute Aortic Dissection (IRAD) Investigators. Predicting death in patients with acute type a aortic dissection. Circulation 105 (2002) 200-206
4. Ehrlich M.P., Schillinger M., Grabenwoger M., et al. Predictors of adverse outcome and transient neurological dysfunction following surgical treatment of acute type A dissections. Circulation 108 II (2003) 318-323
5. Ehrlich M., Fang W.C., Grabenwoger M., et al. Perioperative risk factors for mortality in patients with acute type A aortic dissection. Circulation 98 II (1998) 294-298
6. Trimarchi S., Nienaber C.A., Rampoldi V., et al. Preoperative predictive risk model for mortality in patients with acute type A aortic dissection undergoing surgery: lessons from the International Registry of Acute Aortic Dissection (IRAD). J Am Coll Cardiol 41 (2003) 512-513
7. Mehta R.H., O'Gara P.T., Bossone E., et al., International Registry of Acute Aortic Dissection (IRAD) Investigators. Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol 40 (2002) 685-692
8. Bossone E., Rampoldi V., Nienaber C.A., et al., International Registry of Acute Aortic Dissection (IRAD) Investigators. Usefulness of pulse deficit to predict in-hospital complications and mortality in patients with acute type A aortic dissection. Am J Cardiol 89 (2002) 851-855
9. Koster A., Fischer T., Praus M., et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 97 (2002) 837-841
10. Schillinger M., Domanovits H., Bayegan K., et al. C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 28 (2002) 740-745
11. Kilger E., Weis F., Briegel J., et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31 (2003) 1068-1074
12. Warren B.L., Eid A., Singer P., et al., KyberSept Trial Study Group. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286 (2001) 1869-1878
13. Eisele B., Lamy M., Thijs L.G., et al. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 24 (1998) 663-672
14. Inthorn D., Hoffmann J.N., Hartl W.H., Muhlbayer D., and Jochum M. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock 10 (1998) 90-96
15. Lane D.A., Bayston T., Olds R.J., et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 77 (1997) 197-211
16. Erbel R., Alfonso F., Boileau C., et al. Task force of the ESC: diagnosis and management of aortic dissection. Eur Heart J 22 (2001) 1642-1648
17. Levy M.M., Fink M.P., Marshall J.C., et al., SCCM/ESICM/ACCP/ATS/SIS. Proceedings of the 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31 (2003) 1250-1256
18. Lechner K., and Kyrle P.A. Antithrombin III concentrates-are they clinically useful?. Thromb Haemost 73 (1995) 340-348
19. Weber T., Hogler S., Auer J., et al. D-dimer in acute aortic dissection. Chest 123 (2003) 1375-1378
20. Adam D.J., Haggart P.C., Ludlam C.A., and Bradbury A.W. Hemostatic markers before operation in patients with acutely symptomatic nonruptured and ruptured infrarenal abdominal aortic aneurysm. J Vasc Surg 35 (2002) 661-665
21. Ranucci M., Cazzaniga A., Soro G., et al. The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits. J Cardiothorac Vasc Anesth 16 (2002) 316-320